SOLID DRUG FORM OF N (2 6 BIS(1 METHYLETHYL)PHENYL) N ((1 (4 (DIMETHYLAMINO)PHENYL)CYCLOPENTYL) METHYL)UREA HYDROCHLORIDE AND COMPOSITIONS METHODS AND KITS RELATED THERETO
HUNT STEPHEN WARREN III,PHILLIPS MARTIN DOUGLAS,MATUNAS ROBERT,CHEN HERMAN,BETANCOURT AIMESTHER,UZARAMA CHARLES,THIBERT ROCH
申请号：
IN201717013185
公开号：
IN201717013185A
申请日:
2017.04.12
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
A novel solid drug form of N (2 6 bis(1 methylethyl)phenyl) N ((1 (4 (dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride (also referred to ATR 101) suitable for oral dosing and to compositions methods and kits relating thereto. ATR 101 has particular utility in the treatment of for example aberrant adrenocortical cellular activity including adrenocortical carcinoma (ACC) congenital adrenal hyperplasia (CAH) and Cushing s syndrome.
